Entry Detail



General Information

Database ID:exR0000314
RNA Name:ADM
RNA Type:mRNA
Chromosome:chr11
Starnd:+
Coordinate:
Start Site(bp):10305073End Site(bp):10307397
External Links:ENSG00000148926



Disease Information

Disease Name:Down Syndrome
Disease Category:Congenital, Hereditary, and Neonatal Diseases and Abnormalities
MeSH ID:D004314
Type:Diseases Category/Congenital, Hereditary, and Neonatal Diseases and Abnormalities
Alias:Syndrome, Down//Mongolism//47,XY,+21//Trisomy G//47,XX,+21//Down's Syndrome//Downs Syndrome//Syndrome, Down's//Trisomy 21//Trisomy 21, Mitotic Nondisjunction//Down Syndrome, Partial Trisomy 21//Partial Trisomy 21 Down Syndrome//Trisomy 21, Meiotic Nondisjunction



Expression Detail

GEO ID:GSE16176
Description:Expression profiles of amniotic fluid from human fetuses with Down syndrome and euploid controls
Experimental Design:Disease vs Control
Case Disease Type:Down Syndrome
Case Disease SubType:NA
Case Sample:Down Syndrome
Control Sample:Normal
Number of Case:7
Number of Control:7
Number of Samples:14





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
RASIP1
chr19
48720585
48740610
-
YWHAG
chr7
76326799
76358991
-
SCRIB
chr8
143790920
143815773
-
CARHSP1
chr16
8852942
8869012
-
FAU
chr11
65120630
65122177
-
DOLK
chr9
128945530
128947603
-
TMEM39B
chr1
32072031
32102866
+
ATP13A3
chr3
194402672
194498364
-
PIEZO1
chr16
88715338
88785220
-
MCUB
chr4
109560209
109688719
+
SSR2
chr1
156009048
156020951
-
ARPC3
chr12
110434823
110450422
-
PSMC4
chr19
39971165
39981764
+
THOC3
chr5
175917873
176034680
-
PRELID3B
chr20
59033145
59042809
-
CBX3
chr7
26201162
26213607
+
SNX19
chr11
130875436
130916509
-
STAT1
chr2
190908460
191020960
-
HSP90AB1
chr6
44246166
44253888
+
PSMF1
chr20
1113240
1189415
+
COQ10A
chr12
56266858
56270966
+
SRSF7
chr2
38743599
38751494
-
DDIT4
chr10
72273924
72276036
+
OSGIN2
chr8
89901849
89927888
+
IRS4
chrX
108732482
108736409
-
CENPP
chr9
92325953
92620529
+
LCMT1
chr16
25111731
25178231
+
PACS1
chr11
66070272
66244744
+
ATP1B3
chr3
141876124
141926549
+
EPS15
chr1
51354263
51519266
-
miRNA targets:
miRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa-miR-92a-3p
chrX
134169544
134169565
-
hsa-miR-363-3p
chrX
134169382
134169403
-
hsa-miR-367-3p
chr4
112647877
112647898
-
hsa-miR-92b-3p
chr1
155195237
155195258
+
circRNA targets:NA
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC069281.2
chr7
100572232
100578700
-
AC073111.3
chr7
150379329
150410597
+
PAUPAR
chr11
31812307
32002405
+
Display:



Experiment Detail

GEO ID:GSE16176
Sample Source:Amniotic Fluid
Source Fraction:Supernatant
Platform:GPL570
Method:Microarray
Num of detected RNA Type:1
Num of detected RNAs of this Type:17063
Sample treatment protocol:NA
RNA Extract protocol:RNA was extracted from 10 mL AF with 30 mL TRIzol LS Reagent (Invitrogen, Carlsbad, CA) and 8 mL chloroform. After RNA extraction, RNA was purified and DNA was removed using the RNeasy® Maxi Kit, including the DNase step according to the manufacturer's protocol (QIAGEN, Valencia, CA). RNA was precipitated using 3M NaOAc and 100% ethanol, and 80% ethanol was added after 4 hours incubation at -20 °C. cDNA, synthesized from extracted RNA, was amplified and purified using the WT-Ovation™ Pico RNA Amplification System (NuGEN, San Carlos, CA) and the DNA Clean & Concentrator™-25 (Zymo Research, Orange, CA).
RNA library preparation protocol:biotin Samples were labeled using the FL-Ovation™ cDNA Biotin Module V2 (NuGEN, San Carlos, CA).



Reference

PMID:19474297
Title:Functional genomic analysis of amniotic fluid cell-free mRNA suggests that oxidative stress is significant in Down syndrome fetuses
Author:Slonim DK, Koide K, Johnson KL, Tantravahi U, Cowan JM, Jarrah Z, Bianchi DW
Journal:Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9425-9.
Description:To characterize the differences between second trimester Down syndrome (DS) and euploid fetuses, we used Affymetrix microarrays to compare gene expression in uncultured amniotic fluid supernatant samples.